In this week's video, Dr. Brian G.M. Durie explains how bispecific antibodies work and why they are being studied in clinical trials to treat myeloma.
Bottom Line:
Bispecific antibodies are showing great promise in clinical trials.
Please subscribe to our channel!
Subscribe to International Myeloma Foundation: [ Ссылка ]
Visit our website at: [ Ссылка ]
Find us online:
Facebook: [ Ссылка ]
Google+: [ Ссылка ]
IMF on twitter: @IMFMyeloma ([ Ссылка ])
Dr. Durie on twitter: @BrianDurieMD ([ Ссылка ])
Support the IMF! [ Ссылка ]
Category
Nonprofits & Activism
License
Standard YouTube License
![](https://i.ytimg.com/vi/mDR9YFXB7Ms/maxresdefault.jpg)